Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year revenue growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-14.6x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | -27.93% |
| Q2 2025 | -15.20% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | -82.35% |
| Q3 2023 | 27.27% |
| Q2 2023 | -18.03% |
| Q1 2023 | -0.27% |
| Q4 2022 | 6.87% |
| Q3 2022 | -31.46% |
| Q2 2022 | -13.92% |
| Q1 2022 | 3.34% |
| Q4 2021 | 9.83% |
| Q3 2021 | -5.39% |
| Q2 2021 | 4.23% |
| Q1 2021 | 10.22% |
| Q4 2020 | -1.05% |
| Q3 2020 | 4.61% |
| Q2 2020 | -20.87% |
| Q1 2020 | 30.55% |
| Q4 2019 | -4.71% |
| Q3 2019 | 20.32% |
| Q2 2019 | 0.00% |
| Q1 2019 | 1.05% |
| Q4 2018 | 21.90% |
| Q3 2018 | -2.56% |
| Q2 2018 | 1.91% |
| Q1 2018 | 2.41% |
| Q4 2017 | 26.84% |
| Q3 2017 | -11.61% |
| Q2 2017 | 6.86% |
| Q1 2017 | 24.71% |
| Q4 2016 | -4.90% |
| Q3 2016 | -3.50% |
| Q2 2016 | -6.55% |
| Q1 2016 | 0.82% |